LUPIN
Back to Balance Sheet
|
LUPIN Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹12,651 Cr | ₹8,961 Cr | ₹8,502 Cr | ₹9,265 Cr | ₹8,276 Cr |
What is the latest Total Current Liabilities ratio of LUPIN ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹12,651 Cr |
| Mar2025 | ₹8,961 Cr |
| Mar2024 | ₹8,502 Cr |
| Mar2023 | ₹9,265 Cr |
| Mar2022 | ₹8,276 Cr |
How is Total Current Liabilities of LUPIN Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹12,651 Cr | 41.17 | |
| Mar2025 | ₹8,961 Cr | 5.41 | |
| Mar2024 | ₹8,502 Cr | -8.24 | |
| Mar2023 | ₹9,265 Cr | 11.95 | |
| Mar2022 | ₹8,276 Cr | - | |
Compare Total Current Liabilities of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹99,599.9 Cr | 0.1% | -9.8% | 10.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | 0.1% |
-9.8% |
10.7% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses